Nasacort and Conjunctivitis aggravated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis aggravated is reported as a side effect among people who take Nasacort (triamcinolone acetonide), especially for people who are female, 60+ old, also take Differin, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Conjunctivitis aggravated when taking Nasacort. It is created by eHealthMe based on reports of 12,923 people who have side effects when taking Nasacort from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Conjunctivitis aggravated?

Conjunctivitis aggravated (infection of conjunctiva) is found to be associated with 1,045 drugs and 366 conditions by eHealthMe. Check the latest studies of Conjunctivitis aggravated.

On Jul, 19, 2026

12,923 people reported to have side effects when taking Nasacort.
Among them, 24 people (0.19%) have Conjunctivitis aggravated.

Could Nasacort cause Conjunctivitis aggravated?

Among these 24 people:

What is the gender of people who have Conjunctivitis aggravated when taking Nasacort? *

female: 90.48 %
male: 9.52 %

What is the age of people who have Conjunctivitis aggravated when taking Nasacort? *

What are other drugs people take besides Nasacort? *

What are other side effects people have besides Conjunctivitis aggravated? *

Fatigue (feeling of tiredness): 11 people, 45.83%
Nasopharyngitis (inflammation of the nasopharynx): 10 people, 41.67%
Back Pain: 10 people, 41.67%
Cough: 10 people, 41.67%
Fever: 9 people, 37.50%
Joint Pain: 9 people, 37.50%
Weight Decreased: 8 people, 33.33%
Headache (pain in head): 8 people, 33.33%
Speech Impairment (Adult) (inability to speak (adult)): 8 people, 33.33%
Nausea (feeling of having an urge to vomit): 8 people, 33.33%

What are the existing conditions these people have? *

Asthma: 3 people, 12.50%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 12.50%
Depression: 3 people, 12.50%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 12.50%
Immunodeficiency Common Variable: 2 people, 8.33%
Hypersensitivity: 2 people, 8.33%
Diabetes: 1 person, 4.17%
Cyst (a closed sac): 1 person, 4.17%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 4.17%
Weight Loss: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and have Conjunctivitis aggravated?

- Check whether Conjunctivitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasacort:

Nasacort (13,298 reports)

Browse all side effects of Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis aggravated:

Conjunctivitis aggravated (1,045 drugs)

Browse all the conditions that are associated with Conjunctivitis aggravated:

Conjunctivitis aggravated (366 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Nasacort) and Nasacort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.